You are here

Neulasta

Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar

Fierce Pharma Marketing

Wed, 07/22/15 - 09:36 pm

The top 10 patent losses of 2015

Fierce Pharma

Fri, 12/19/14 - 08:35 am

Bristol-Myers Squibb

Teva Pharmaceutical

Amgen's Neulasta Succeeds in Phase 3 Cancer Trial

Motley Fool

Mon, 01/28/13 - 12:29 pm

colorectal cancer

Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta In Patients With Colorectal Cancer

Yahoo/PR Newswire

Sat, 01/26/13 - 11:52 am

colorectal cancer

No Drug Can Cure the Health-Care Reform Infection

Motley Fool

Thu, 04/22/10 - 08:12 pm

healthcare reform

Abbott Laboratories

Pages